Back to Trades
Sell4
ASP Isotopes Inc.
ASPI
Total Value
$1.1M
Net $71.9K sold
Sales
$71.9K
1 transaction
Company Information
- Company Name
- ASP Isotopes Inc.
- Ticker Symbol
- ASPI
- CIK
- 0001921865
Insider Information
- Name
- Ainscow Robert
- Role
- Insider
- Location
- WASHINGTON, DC
Filing Details
- Filing Date
- Sep 10, 2025
- Transaction Date
- Invalid Date
- Accession Number
- 0001477932-25-006620
- Form Type
- 4
- Net Trading Amount
- -$71.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Invalid Date | Common Stock | 8,438 | $8.53 | Sale | $71.9K |
| Invalid Date | Common Stock | 150,000 | $0.25 | Exercise | $37.5K |
| Invalid Date | Common Stock | 4,396 | $8.53 | Tax Withholding | $37.5K |
| Invalid Date | Common Stock | 12,000 | $2.00 | Exercise | $24.0K |
| Invalid Date | Common Stock | 2,813 | $8.53 | Tax Withholding | $24.0K |
| Invalid Date | Common Stock | 135,000 | $2.00 | Exercise | $270.0K |
| Invalid Date | Common Stock | 31,652 | $8.53 | Tax Withholding | $270.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Invalid Date | Derivative | 150,000 | $0.25 | Exercise | $37.5K |
| Invalid Date | Derivative | 12,000 | $2.00 | Exercise | $24.0K |
| Invalid Date | Derivative | 135,000 | $2.00 | Exercise | $270.0K |
Footnotes
- (F1)Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $8.79, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
- (F3)Represents shares withheld by the Company in connection with net share settlement to satisfy the exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or any tax liability.
- (F4)These options vested in thirty-six equal installments beginning on the last day of month after the option's grant date. The option was granted on October 4, 2021.
- (F5)These options vested in a single installment 12 months after the grant date. The option was granted on April 4, 2022.
- (F6)These options vested in thirty-six equal installments beginning on the last day of month after the option's grant date. The option was granted on June, 10, 2022.